Progress of transcatheter aortic valve replacement in patients with atrioventricular regurgitation
- VernacularTitle:合并房室瓣反流患者行经导管主动脉瓣置换术的研究进展
- Author:
Yang CHENG
1
;
Fei CHEN
1
;
Xi LI
1
;
Lei ZHU
1
;
Mao CHEN
1
Author Information
1. Department of Cardiology, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China
- Publication Type:Journal Article
- Keywords:
Transcatheter aortic valve replacement;
aortic valve stenosis;
mitral regurgitation;
tricuspid regurgitation;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2023;30(08):1193-1198
- CountryChina
- Language:Chinese
-
Abstract:
As the indications for transcatheter aortic valve replacement (TAVR) expand, multi-valve lesions are becoming more common in clinical practice. Moderate to severe atrioventricular regurgitation, particularly when persistent after TAVR, significantly increases the risk of adverse events. Therefore, many studies have evaluated factors that contribute to the improvement of atrioventricular regurgitation. However, this field remains controversial due to the heterogeneity of retrospective studies and the lack of randomized controlled trials. Despite advances in atrioventricular valve intervention techniques, evidence for atrioventricular regurgitation intervention after TAVR is still scarce. The management decision for atrioventricular regurgitation in patients who underwent TAVR is complex and must take into account the severity of valve disease, anatomical characteristics, quality of life, and procedural complexity. We conducted a review of atrioventricular regurgitation in patients who have received TAVR in hope that it will help decision-making in clinical practice.
